Heparin for assisted reproduction Summary of a Cochrane review

Current evidence does not justify the use of periimplantation heparin in women undergoing assisted reproductive techniques.

Like Comment

Authors

Muhammad Ahsan Akhtar, M.B.B.S., Shyamaly Sur, Ph.D., Nick Raine-Fenning, Ph.D., Kannamannadiar Jayaprakasan, Ph.D., Jim Thornton, M.D., Siobhan Quenby, M.D., Jane Marjoribanks, M.P.H.

Volume 103, Issue 1, Pages 33-34

Abstract

It is suggested that heparin given in the peri-implantation period may improve clinical outcomes in women undergoing assisted reproduction techniques (ART). This systematic review evaluates the use of heparin in subfertile women undergoing ART.

Read the full text at: http://www.fertstert.org/article/S0015-0282(14)02157-8/fulltext


Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

No comments yet.